USPTO serial 97819809
IVIG IS OUR MIDDLE NAME
Reviewed by CopyMark Law Group
Status 734Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- THOMAS-RIGGS, LESLIE A
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with IVIG IS OUR MIDDLE NAME?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $549*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 THOMAS JEFFERSON STREET, NWSUITE 400WASHINGTON, DC 20007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 016 | Printed materials, namely, newsletters, articles and case studies featuring immunoglobulin, immunodeficiency and neurological disorders; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of immunoglobulin, immunodeficiency and neurological disorders; printed educational materials in the field of immunoglobulin, immunodeficiency and neurological disorders | ACTIVE | — |
| 035 | Healthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals | ACTIVE | — |
| 041 | Healthcare education services, namely, conducting educational programs for patients, caregivers and/or healthcare professionals concerning immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; planning and conducting educational conventions and educational meetings related to immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals | ACTIVE | — |
| 044 | Providing a website featuring healthcare information in the field of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Providing a website featuring information in the field of the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders; Providing links to the web sites of others featuring information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CSL Behring AG
- Other trademarks owned by CSL Behring AG
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named IVIG IS OUR MIDDLE NAME
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 3, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Aug 3, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 31, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 30, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Oct 8, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 30, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 30, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 30, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 1, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 31, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 31, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 31, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 24, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 24, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 24, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 24, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 2, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 1, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 1, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 31, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 5, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 5, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 16, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 2, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 1, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 1, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 1, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 10, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 10, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 10, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 22, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 6, 2023 | NWAP | NEW APPLICATION ENTERED | — |